Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Feng-Ming Spring Kong

Showing results (11-20 of 169) with videos related to

Pageof 17
Sort By:
Translational Lung Cancer Research|December 9, 2017
Potential future consideration for imaging and blood-based biomarkers for precision medicine in lung cancerFeng-Ming Spring Kong, Fred R Hirsch, Mitchell Machtay
Practical Radiation Oncology|July 2, 2018
Review of thoracic reirradiation with stereotactic body radiation therapy: A focus on toxicity risksMichael T Milano, Alina Mihai, Feng-Ming Spring Kong
Hematology/Oncology Clinics of North America|May 30, 2006
The role of radiation therapy in thoracic tumorsFeng-Ming Spring Kong, Lujun Zhao, James A Hayman
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 17, 2012
Imaging during radiation therapy captures abrupt and dramatic changesFeng-Ming Spring Kong, Ka Kit Wong, Timothy Ritter
International Journal of Radiation Oncology, Biology, Physics|August 2, 2016
Comparison of the Effectiveness of Radiofrequency Ablation With Stereotactic Body Radiation Therapy in Inoperable Stage I Non-Small Cell Lung Cancer: A Systemic Review and Pooled AnalysisNan Bi, Kerby Shedden, Xiangpeng Zheng, et al.
Journal of Thoracic Disease|July 10, 2020
Predicting liver and lung metastasis in esophageal cancer: does the site of primary tumor really matter?Ka-On Lam, Tsz-Him So, Feng-Ming Spring Kong
Clinical Lung Cancer|November 8, 2011
Negative predictive value of positron emission tomography and computed tomography for stage T1-2N0 non-small-cell lung cancer: a meta-analysisJingbo Wang, Kathy Welch, Luhua Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2025
Reply to: Mid-Treatment Positron Emission Tomography-Adaptive Radiotherapy in Stage III Non-Small Cell Lung Cancer: Another Attempt Toward Personalized CareFeng-Ming Spring Kong, Chen Hu, Jeffrey D Bradley, et al.
Journal of Thoracic Disease|April 2, 2014
Radiation dose effect in locally advanced non-small cell lung cancerFeng-Ming Spring Kong, Jing Zhao, Jingbo Wang, et al.
Seminars in Radiation Oncology|March 31, 2007
Physical models and simpler dosimetric descriptors of radiation late toxicityFeng-Ming Spring Kong, Charlie Pan, Avraham Eisbruch, et al.
Pageof 17

Showing results (11-20 of 169) with videos related to

Sort By:
Pageof 17
Translational Lung Cancer Research|December 9, 2017
Potential future consideration for imaging and blood-based biomarkers for precision medicine in lung cancerFeng-Ming Spring Kong, Fred R Hirsch, Mitchell Machtay
Practical Radiation Oncology|July 2, 2018
Review of thoracic reirradiation with stereotactic body radiation therapy: A focus on toxicity risksMichael T Milano, Alina Mihai, Feng-Ming Spring Kong
Hematology/Oncology Clinics of North America|May 30, 2006
The role of radiation therapy in thoracic tumorsFeng-Ming Spring Kong, Lujun Zhao, James A Hayman
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 17, 2012
Imaging during radiation therapy captures abrupt and dramatic changesFeng-Ming Spring Kong, Ka Kit Wong, Timothy Ritter
International Journal of Radiation Oncology, Biology, Physics|August 2, 2016
Comparison of the Effectiveness of Radiofrequency Ablation With Stereotactic Body Radiation Therapy in Inoperable Stage I Non-Small Cell Lung Cancer: A Systemic Review and Pooled AnalysisNan Bi, Kerby Shedden, Xiangpeng Zheng, et al.
Journal of Thoracic Disease|July 10, 2020
Predicting liver and lung metastasis in esophageal cancer: does the site of primary tumor really matter?Ka-On Lam, Tsz-Him So, Feng-Ming Spring Kong
Clinical Lung Cancer|November 8, 2011
Negative predictive value of positron emission tomography and computed tomography for stage T1-2N0 non-small-cell lung cancer: a meta-analysisJingbo Wang, Kathy Welch, Luhua Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2025
Reply to: Mid-Treatment Positron Emission Tomography-Adaptive Radiotherapy in Stage III Non-Small Cell Lung Cancer: Another Attempt Toward Personalized CareFeng-Ming Spring Kong, Chen Hu, Jeffrey D Bradley, et al.
Journal of Thoracic Disease|April 2, 2014
Radiation dose effect in locally advanced non-small cell lung cancerFeng-Ming Spring Kong, Jing Zhao, Jingbo Wang, et al.
Seminars in Radiation Oncology|March 31, 2007
Physical models and simpler dosimetric descriptors of radiation late toxicityFeng-Ming Spring Kong, Charlie Pan, Avraham Eisbruch, et al.
Pageof 17